Skip to main content

Lumexa Imaging Holdings, Inc.

corporate_fare Company Profile

Lumexa Imaging Holdings, Inc.

LMRI·NASDAQ·Industrial Applications And Services·CIK 0002071288

Lumexa Imaging Holdings, Inc. is one of the largest national providers of diagnostic imaging services. As of December 31, 2025, the company and its affiliates operated the second largest outpatient imaging center footprint in the United States, comprising 188 centers across 13 states. This includes eight joint venture partnerships with health systems. Of these 188 centers, 102 were owned by the company's wholly owned subsidiaries and variable interest entities. These centers are located in metropolitan service areas that experienced an average annual population growth of approximately 1.4% on a center-weighted basis between 2020 and 2024. The centers are designed for easy access, featuring convenient retail settings and extended operating hours. Lumexa Imaging Holdings, Inc. has a diversified network of approximately 102,000 referring physicians, representing more than 32,000 physician practices in 2025. The company utilizes best-in-class equipment and technology, staffed by skilled technologists and subspecialized radiologists. Magnetic resonance imaging ("MRI") and computed tomography ("CT") referrals were a key driver of revenue growth, accounting for 52% of consolidated revenue and 63% of system-wide revenue for the year ended December 31, 2025.

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for LMRI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-13, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 8/10, with 10 rated 8 or above. Recent SEC coverage for LMRI spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Lumexa Imaging Reports Q2 Profitability, Strong Operating Cash Flow
  • Lumexa Imaging Swings to Q2 Profit, Reiterates 2026 Outlook
  • Lumexa Imaging Q2 2026: Net Income Turns Positive, Guidance Narrowed
  • Lumexa Imaging Secures $1.07 Billion in New Debt to Refinance, Boost Liquidity
  • Lumexa Imaging Refinances $823M Term Loan, Extends Debt Maturities
Browse all tickers starting with L →
$11.05 -0.03% today
52-week range · as of 2026-08-13 $6.45 – $19.45
Market cap
$1.06B
Volume
678.2K (1.5× avg)
3-mo avg 441.9K
Live data · 2026-09-21 04:39 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed LMRI - Latest Insights

LMRI
Aug 13, 2026, 2:54 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $12.30
Real-time Price: $11.05 info
Change: -$1.24 (-10%) info
Market Cap: $1.065B info
LMRI
Aug 12, 2026, 4:18 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $12.00
Real-time Price: $11.05 info
Change: -$0.950 (-8%) info
Market Cap: $1.065B info
LMRI
Aug 12, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.06
Real-time Price: $11.05 info
Change: -$1.01 (-8%) info
Market Cap: $1.065B info
LMRI
Jun 30, 2026, 5:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $11.28
Real-time Price: $11.05 info
Change: -$0.230 (-2%) info
Market Cap: $1.065B info
LMRI
Jun 30, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.28
Real-time Price: $11.05 info
Change: -$0.230 (-2%) info
Market Cap: $1.065B info
LMRI
Jun 02, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $7.35
Real-time Price: $11.05 info
Change: +$3.70 (+50%) info
Market Cap: $1.065B info
LMRI
May 12, 2026, 4:21 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $10.50
Real-time Price: $11.05 info
Change: +$0.550 (+5%) info
Market Cap: $1.065B info
LMRI
May 12, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $11.15
Real-time Price: $11.05 info
Change: -$0.100 (-0.90%) info
Market Cap: $1.065B info
LMRI
May 12, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.50
Real-time Price: $11.05 info
Change: +$0.550 (+5%) info
Market Cap: $1.065B info
LMRI
Mar 30, 2026, 5:32 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $7.97
Real-time Price: $11.05 info
Change: +$3.08 (+39%) info
Market Cap: $1.065B info
LMRI
Mar 26, 2026, 6:09 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.06
Real-time Price: $11.05 info
Change: -$0.0100 (-0.09%) info
Market Cap: $1.065B info
LMRI
Mar 26, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $11.06
Real-time Price: $11.05 info
Change: -$0.0100 (-0.09%) info
Market Cap: $1.065B info
LMRI
Mar 02, 2026, 9:12 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $14.14
Real-time Price: $11.05 info
Change: -$3.09 (-22%) info
Market Cap: $1.065B info
LMRI
Mar 02, 2026, 6:14 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $14.14
Real-time Price: $11.05 info
Change: -$3.09 (-22%) info
Market Cap: $1.065B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets